Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Feb 21;177(2):243–253. doi: 10.1111/bjh.14534

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 The Authors. British Journal of Haematology published by John Wiley & Sons Ltd.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Treatment Response. (A) Overall response by lymphoma subtype. (B) Individual patient best percentage change from baseline in nodal size. (C) Progression‐free survival. aNHL, aggressive non‐Hodgkin lymphoma; CI, confidence interval; CLL, chronic lymphocytic leukaemia; CR, complete response; DLBCL, diffuse large B‐cell lymphoma; FL, follicular lymphoma; iNHL, indolent non‐Hodgkin lymphoma; MCL, mantle cell lymphoma; MZL, marginal zone lymphoma; ORR, overall response rate; PD, progressive disease; PFS, progression‐free survival; PR, partial response; SD, stable disease.